rituximab

Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire
Sabrina Pollastro, Paul L Klarenbeek, Marieke E Doorenspleet, Barbera D C van Schaik, Rebecca E E Esveldt, Rogier M Thurlings, Maria J H Boumans, Danielle M Gerlag, Paul P Tak, Koen Vos, Frank Baas, Antoine H C van Kampen, Niek de Vries

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2018-214898; DOI: 10.1136/annrheumdis-2018-214898
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study
Marc Scherlinger, Claire Carcaud, Marie-Elise Truchetet, Thomas Barnetche, Pierre Duffau, Lionel Couzi, Julien Seneschal, Patrick Blanco, Estibaliz Lazaro, Christophe Richez

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 1007-1010; DOI: 10.1136/annrheumdis-2018-214833
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov, Alain Lescoat, Elise Siegert, Ivan Castellví, Paolo Airó, Serena Vettori, Ellen De Langhe, Eric Hachulla, Anne Erler, Lidia Ananieva, Martin Krusche, F J López-Longo, Jörg H W Distler, Nicolas Hunzelmann, Anna-Maria Hoffmann-Vold, Valeria Riccieri, Vivien M Hsu, Maria R Pozzi, Codrina Ancuta, Edoardo Rosato, Carina Mihai, Masataka Kuwana, Lesley Ann Saketkoo, Carlo Chizzolini, Roger Hesselstrand, Susanne Ullman, Sule Yavuz, Simona Rednic, Cristian Caimmi, Coralie Bloch-Queyrat, Yannick Allanore

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 979-987; DOI: 10.1136/annrheumdis-2018-214816
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
Danielle M Gerlag, Mary Safy, Karen I Maijer, Man Wai Tang, Sander W Tas, Mirian J F Starmans-Kool, Astrid van Tubergen, Matthijs Janssen, Maria de Hair, Monika Hansson, Niek de Vries, Aeilko H Zwinderman, Paul P Tak

Annals of the Rheumatic Diseases Feb 2019, 78 (2) 179-185; DOI: 10.1136/annrheumdis-2017-212763
Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
Andreas Kronbichler, Julia Kerschbaum, Seerapani Gopaluni, Joanna Tieu, Federico Alberici, Rachel Bronwen Jones, Rona M Smith, David R W Jayne

Annals of the Rheumatic Diseases Oct 2018, 77 (10) 1440-1447; DOI: 10.1136/annrheumdis-2017-212861
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis
Giacomo Emmi, Giovanni M Rossi, Maria L Urban, Elena Silvestri, Domenico Prisco, Matteo Goldoni, Augusto Vaglio

Annals of the Rheumatic Diseases Jun 2018, 77 (6) 952-954; DOI: 10.1136/annrheumdis-2017-211897
Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy
Huifeng Yun, Fenglong Xie, Elizabeth Delzell, Lang Chen, Emily B Levitan, James D Lewis, Kenneth G Saag, Timothy Beukelman, Kevin Winthrop, John W Baddley, Jeffrey R Curtis

Annals of the Rheumatic Diseases Jun 2015, 74 (6) 1065-1071; DOI: 10.1136/annrheumdis-2013-204011

Log in using your username and password

Main menu

Log in using your username and password

You are here

rituximab